Liposomal Tumor Targeting in Drug Delivery Utilizing MMP-2- and MMP-9-Binding Ligands
Figure 5
Tissue distribution of a single dose of 125I-CTT2-peptide in immunosuppressed OV-90 xenograft mice. Blood and major organs/tissues were collected at 0.5 hr and 3 hrs p.i. 125I-CTT2-peptide (40 μg/mouse, ) and their radioactivities were measured. Results are expressed as percentage of injected dose per gram tissue (%ID/g). All values are given as mean ± SD.
